Topic: MS

Secondary-progressive multiple sclerosis (SPMS)

July 20, 2021  

New failed trials of intrathecal rituximab in PMS

July 9, 2021  

T25FW useful to identify early progression in MS

June 29, 2021  

COVID vaccination and anti-CD20s – an update

June 28, 2021  

Highlights from EAN 2021

June 22, 2021  

COVID-19 mortality in MS patients: a systematic review

June 1, 2021  

Anti-CD20 therapies – Mechanisms of action

May 25, 2021  

MS Clinics Network updates COVID vaccine guidance

May 3, 2021  

Are trial data generalizable to MS population?

April 27, 2021  

Few vaccine responders with fingolimod, ocrelizumab

April 23, 2021